Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Journal of Pediatric Hematology/Oncology|January 5, 2018
Incidentally Detected Transfusion-associated Iron Overload in 3 Children After Cancer ChemotherapyDennis John Kuo, Pooja Bhagia
Pediatric Blood & Cancer|May 7, 2011
Sinonasal adenocarcinoma: a rare second malignancy in long term retinoblastoma survivorsPooja Bhagia, Agnes Basas Colanta, David H Abramson, et al.
Future Oncology (London, England)|May 12, 2021
KEYNOTE-859: a Phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinomaJosep Tabernero, Yung-Jue Bang, Eric Van Cutsem, et al.
Blood|October 24, 2014
Isolation and transcriptome analyses of human erythroid progenitors: BFU-E and CFU-EJie Li, John Hale, Pooja Bhagia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2023
Event-Free Survival as a Surrogate for Overall Survival in Gastric and Gastroesophageal Junction Adenocarcinoma: A Meta-analysis in the Neoadjuvant ± Adjuvant SettingZev A Wainberg, Jipan Xie, Adriana Valderrama, et al.
Future Oncology (London, England)|May 2, 2024
LEAP-014: first-line lenvatinib + pembrolizumab + chemotherapy in advanced/metastatic esophageal squamous cell carcinomaJong-Mu Sun, Antoine Adenis, Peter C Enzinger, et al.
Esophagus : Official Journal of the Japan Esophageal Society|September 30, 2021
Second-line pembrolizumab versus chemotherapy in Japanese patients with advanced esophageal cancer: subgroup analysis from KEYNOTE-181Kei Muro, Takashi Kojima, Toshikazu Moriwaki, et al.
Future Oncology (London, England)|February 3, 2021
KEYNOTE-975 study design: a Phase III study of definitive chemoradiotherapy plus pembrolizumab in patients with esophageal carcinomaManish A Shah, Jaafar Bennouna, Toshihiko Doi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2021
Impact of Pembrolizumab Versus Chemotherapy as Second-Line Therapy for Advanced Esophageal Cancer on Health-Related Quality of Life in KEYNOTE-181Antoine Adenis, Amit S Kulkarni, Gustavo C Girotto, et al.
Future Oncology (London, England)|November 10, 2020
First-line pembrolizumab/placebo plus trastuzumab and chemotherapy in HER2-positive advanced gastric cancer: KEYNOTE-811Hyun Cheol Chung, Yung-Jue Bang, Charles S Fuchs, et al.
Pageof 3